2026-2034年病毒衣殼開發全球市場規模、佔有率、趨勢和成長分析報告

全球病毒衣殼開發市場預計將從2025年的3.3476億美元成長至2034年的8.2357億美元，2026年至2034年的複合年成長率（CAGR）為10.52%。隨著基因療法、疫苗研發和先進生技藥品不斷變革現代醫療保健，該市場正經歷顯著成長。病毒衣殼在治療性基因和疫苗的精準遞送中發揮著至關重要的作用，也是基因編輯、細胞療法和病毒載體生產的關鍵組成部分。對生物技術研發、精準醫療和先進療法開發的投資不斷增加，正強勁推動全球對病毒衣殼開發技術的需求。

利用腺結合病毒、慢病毒載體和其他病毒遞送平台進行的臨床研究的擴展，正在加速整個製藥和生物技術產業的創新。衣殼工程、蛋白質修飾、載體最佳化和可擴展生產過程等方面的技術進步，正在提高治療效率、靶向精準度和生產能力。遺傳性疾病盛行率的上升和對創新療法需求的不斷成長，進一步推動了市場成長。

隨著基因療法法規核准的增加和個人化醫療的日益普及，預計該市場將顯著擴張。合成生物學、人工智慧（AI）驅動的藥物發現以及新一代病毒載體工程的持續進步將改善治療效果並提升商業性擴充性。不斷擴大的研究合作、醫療保健領域投資的增加以及全球生物技術能力的提升將繼續支撐市場的長期成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球病毒衣殼開發市場：依類型分類

• 市場分析、洞察與預測
• 腺結合病毒（AAV）衣殼
• 腺病毒
• 慢病毒
• 其他

第5章：全球病毒衣殼開發市場：依應用領域分類

• 市場分析、洞察與預測
• 基因治療
• 疫苗研發
• 癌症治療
• 其他

第6章：全球病毒衣殼開發市場：依最終用途分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 學術研究機構
• 合約研究組織 (CRO) 和合約行銷組織 (CMO)

第7章 全球病毒衣殼開發市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • PackGene Biotech Inc
  • VectorBuilder
  • AskBio Inc.（includes Viralgen）
  • Voyager Therapeutics
  • UniQure NV
  • Vigene Biosciences（now Part Of Charles River Laboratories）
  • Capsigen

The global viral capsid development market size is expected to reach USD 823.57 Million in 2034 from USD 334.76 Million in 2025, growing at a CAGR of 10.52 during 2026-2034.This market is experiencing significant growth as gene therapy, vaccine development, and advanced biologics continue transforming modern healthcare. Viral capsids play a crucial role in delivering therapeutic genes and vaccines with high precision, making them essential components in gene editing, cell therapy, and viral vector manufacturing. Increasing investments in biotechnology research, precision medicine, and advanced therapeutic development are driving strong global demand for viral capsid development technologies.

Growing clinical research involving adeno-associated viruses, lentiviral vectors, and other viral delivery platforms is accelerating innovation across the pharmaceutical and biotechnology industries. Technological advancements in capsid engineering, protein modification, vector optimization, and scalable manufacturing processes are improving therapeutic efficiency, targeting accuracy, and production capabilities. Rising prevalence of genetic disorders and increasing demand for innovative treatment approaches are further supporting market growth.

The market is expected to witness substantial expansion as regulatory approvals for gene therapies increase and personalized medicine becomes more widely adopted. Continuous advancements in synthetic biology, artificial intelligence-assisted drug development, and next-generation viral vector engineering will improve therapeutic outcomes and commercial scalability. Expanding research collaborations, increasing healthcare investments, and growing global biotechnology capabilities will continue supporting long-term market growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

• Adeno-Associated Virus (AAV) Capsids
• Adenoviral
• Lentiviral
• Others

By Application

• Gene Therapy
• Vaccine Development
• Cancer Therapy
• Others

By End Use

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• CROs & CMOs

COMPANIES PROFILED

• PackGene Biotech Inc., VectorBuilder, AskBio Inc. (includes Viralgen), Voyager Therapeutics, uniQure N.V., Vigene Biosciences (now part of Charles River Laboratories), Capsigen

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VIRAL CAPSID DEVELOPMENT MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Adeno-Associated Virus (AAV) Capsids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Adenoviral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Lentiviral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VIRAL CAPSID DEVELOPMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Gene Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Vaccine Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cancer Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VIRAL CAPSID DEVELOPMENT MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. CROs & CMOs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VIRAL CAPSID DEVELOPMENT MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL VIRAL CAPSID DEVELOPMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 PackGene Biotech Inc
  • 9.2.2 VectorBuilder
  • 9.2.3 AskBio Inc. (includes Viralgen)
  • 9.2.4 Voyager Therapeutics
  • 9.2.5 UniQure N.V
  • 9.2.6 Vigene Biosciences (now Part Of Charles River Laboratories)
  • 9.2.7 Capsigen